LifeScan Belgium
ActiveSummary
The computed 12-month bankruptcy probability of LifeScan Belgium is 1.7% (moderate). The 2025 annual accounts show equity of €2.1m and a net result of €175,162. Equity has been growing by about 9.6% per year since 2018. Its solvency ranks better than 49% of 12,777 sector peers (NACE 47, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 28-05-2018 Normal situation
- Registered office
- 52 active companies are registered at this address Source: KBO register, as of 4 November 2026.
- Activity
- Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741and 1 other
- Establishment unit
- 2.276.351.755 2260 Westerlo, since 28-05-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 08-01-2026
Board and ownership
- Joyce Van HoekDaily manager
- Youssef LouahraniDaily manager
- James K Rushing JrDirector · since 22-11-2024
- Auditor
- Ernst & Young Bedrijfsrevisoren BV
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.7%
- Gross margin
- €2.2m
- ▼ 39.3%
- Turnover
- ≈ €5.5m
- estimated
- Profit
- €175,162
- ▼ 16.6%
- Equity
- €2.1m
- ▲ 9.2%
- Total assets
- €5.7m
- ▲ 2.6%
- Employees on 31-12-2025
- 13
- =
- 2025 accounts filed 60 days after the deadline
Score breakdownraises riskLast filed accounts filed 60 days late; 2 of the last 3 accounts lateLiquidity: current ratio 7.78lowers riskSize: 12.3 FTE, total assets €5.7mFigures for financial year 2025 (filed on 01-10-2026)Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 56% of them on solvency, 99% on liquidity, 28% on profitability and 64% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 47 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Resignation: Alisandra Rizzolo (director)Appointment: Bimal Desai (director)
- · Gazette deed Resignation: John de Grandpre (director)Appointment: James K Rushing Jr (director)
- · Gazette deed 2 directors appointed, 2 directors resigningResignations: PricewaterhouseCoopers Bedrijfsrevisorern BV (statutory auditor) and Joyce Van Hoeck (day-to-day manager) · Appointments: Ernst & Young Bedrijfsrevisoren BV (statutory auditor) and Youssef Louahrani (day-to-day manager)
Comparable companies
These companies have the same main activity as LifeScan Belgium: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €2.7m and €9.3m, founded between 2013 and 2020.
| Company | Total assets | Gross margin |
|---|---|---|
| LifeScan Belgium Westerlo | €5.7m | €2.2m |
| Veterinary Solutions Hasselt | €4.6m | €2.1m |
| Hego-Mobile Lanaken | €3.7m | €1.8m |
| GOHY GROUP Theux | €3.0m | €1.2m |
| MMM Benelux Tienen | €2.7m | €2.0m |
| Optimal Control Diest | €3.2m | €1.6m |
| MICROPORT ORTHOPEDICS Asse | €9.3m | €2.1m |
Key facts about LifeScan Belgium
- What is the company number of LifeScan Belgium?
- The company number of LifeScan Belgium is 0696.820.779. The VAT number is the same number with BE in front: BE 0696.820.779.
- Where is LifeScan Belgium based?
- The registered office is at Nijverheidsstraat 13, 2260 Westerlo.Company details
- What does LifeScan Belgium do?
- According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
- What is the legal form of LifeScan Belgium?
- The legal form of LifeScan Belgium is Private limited company (BV).
- When was LifeScan Belgium founded?
- LifeScan Belgium was founded on 28-05-2018.
- Is LifeScan Belgium still active?
- Yes, LifeScan Belgium is an active enterprise in the KBO register.
- How many employees does LifeScan Belgium have?
- LifeScan Belgium had an average of 12.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of LifeScan Belgium?
- The turnover in financial year 2025 is ≈ €5.5m. This figure is estimated from the gross margin of €2.2m and 30 comparable companies (NACE 477). It probably lies between €4.3m and €8.1m.
- Is LifeScan Belgium profitable?
- In financial year 2025, LifeScan Belgium made a profit of €175,162.
- Where can I find the annual accounts of LifeScan Belgium?
- LifeScan Belgium filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LifeScan Belgium due?
- LifeScan Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.